Identity
Verified material identity and method.
Controlled values pendingIsolate input and finished-product evidence are separate.
This page shows the planned control structure for the CBD isolate input used in Micelle 60. Controlled acceptance values, methods, and quantitation limits will be published only from verified source documents.
Planned control structure
What the isolate specification will contain.
The final controlled version will identify the material, method, acceptance limit, version, effective date, and source document for each requirement.
CBD assay and purity
Controlled assay, units, basis, method, and acceptance range.
Controlled values pendingOther cannabinoids
Reported analytes, units, detection or quantitation limits, and acceptance criteria.
Controlled values pendingResidual solvents
Method, named solvents, units, limits, and reporting thresholds.
Controlled values pendingPesticides, elemental impurities, and microbiology
Applicable panels, methods, units, and limits from verified documentation.
Controlled values pendingDocument control
Specification version, effective date, approver function, and change history.
Controlled values pendingDocument status
Evidence boundaries are published without substituting another product’s data.
The dated product sheet, sanitized status records and blank format model are publication artifacts. They assert no laboratory values or accreditation.
Dated development description; not released-product specification
Micelle 60 development product sheet
- Version
- 1.0
- Date
- October 1, 2026
- Pages
- 1
- File size
- 46 KB
- Status
- Planned label and pack; genuine control and testing evidence pending
Ingredient evidence status record ASanitized JSON · Version 1.0 · No asserted laboratory valuesIngredient evidence status record BSanitized JSON · Version 1.0 · No asserted laboratory valuesMicelle 60 Example A certificateExample interface document · 2 pages · Sample values only
Format model; no laboratory results
Micelle 60 finished-product certificate format model
- Version
- 1.1
- Date
- 29 September 2026
- Pages
- 3
- File size
- 59 KB
- Status
- In development; not a certificate of analysis or released-lot record
The separate 300 mg NW PharmaTech investigational program is a different product and is not Micelle 60 finished-product evidence. Ingredient results, estimates, and another product’s records are not presented as finished-product testing of Micelle 60. Every illustrative value remains labelled Example.